Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Friedman
S Yusuf

Circulation

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Circulation|February 1, 1986
Does therapy directed by programmed electrical stimulation provide a satisfactory clinical response?L Friedman, S Yusuf
Circulation|September 1, 1995
Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?S Yusuf
Circulation|May 15, 1996
Cost of prevention. The case of lipid loweringS Yusuf, S Anand
Circulation|January 15, 1995
Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trialsK B Michels, S Yusuf
Circulation|March 11, 1998
Emerging epidemic of cardiovascular disease in developing countriesK S Reddy, S Yusuf
Circulation|August 1, 1991
Antiarrhythmics and VPD suppressionC D Furberg, S Yusuf
Circulation|June 1, 1993
Intravenous magnesium in acute myocardial infarction. An effective, safe, simple, and inexpensive interventionS Yusuf, K Teo, K Woods
Circulation|November 1, 1990
Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarctionP H Held, K K Teo, S Yusuf
Circulation|December 6, 2001
Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategiesS Yusuf, S Reddy, S Ounpuu, et al.
Circulation|November 28, 2001
Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanizationS Yusuf, S Reddy, S Ounpuu, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Circulation|February 1, 1986
Does therapy directed by programmed electrical stimulation provide a satisfactory clinical response?L Friedman, S Yusuf
Circulation|September 1, 1995
Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?S Yusuf
Circulation|May 15, 1996
Cost of prevention. The case of lipid loweringS Yusuf, S Anand
Circulation|January 15, 1995
Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trialsK B Michels, S Yusuf
Circulation|March 11, 1998
Emerging epidemic of cardiovascular disease in developing countriesK S Reddy, S Yusuf
Circulation|August 1, 1991
Antiarrhythmics and VPD suppressionC D Furberg, S Yusuf
Circulation|June 1, 1993
Intravenous magnesium in acute myocardial infarction. An effective, safe, simple, and inexpensive interventionS Yusuf, K Teo, K Woods
Circulation|November 1, 1990
Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarctionP H Held, K K Teo, S Yusuf
Circulation|December 6, 2001
Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategiesS Yusuf, S Reddy, S Ounpuu, et al.
Circulation|November 28, 2001
Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanizationS Yusuf, S Reddy, S Ounpuu, et al.
Pageof 6